Gillian Murphy

45.3k total citations · 12 hit papers
314 papers, 38.0k citations indexed

About

Gillian Murphy is a scholar working on Cancer Research, Oncology and Hematology. According to data from OpenAlex, Gillian Murphy has authored 314 papers receiving a total of 38.0k indexed citations (citations by other indexed papers that have themselves been cited), including 239 papers in Cancer Research, 160 papers in Oncology and 95 papers in Hematology. Recurrent topics in Gillian Murphy's work include Protease and Inhibitor Mechanisms (239 papers), Peptidase Inhibition and Analysis (140 papers) and Blood Coagulation and Thrombosis Mechanisms (87 papers). Gillian Murphy is often cited by papers focused on Protease and Inhibitor Mechanisms (239 papers), Peptidase Inhibition and Analysis (140 papers) and Blood Coagulation and Thrombosis Mechanisms (87 papers). Gillian Murphy collaborates with scholars based in United Kingdom, United States and Germany. Gillian Murphy's co-authors include Vera Knäuper, Andrew Docherty, John J. Reynolds, Susan J. Atkinson, Dylan R. Edwards, Frances Willenbrock, Carlos López-Otı́n, Andrew H. Baker, Rosalind M. Hembry and Bryan Ronain Smith and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gillian Murphy

313 papers receiving 36.8k citations

Hit Papers

Transforming growth factor beta modulates the expression ... 1985 2026 1998 2012 1987 2002 1996 1999 1996 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.
    1987 1.1k citations Dylan R. Edwards, Gillian Murphy et al. profile →
  2. Metalloproteinase inhibitors: biological actions and therapeutic opportunities
    2002 926 citations Dylan R. Edwards, Gillian Murphy et al. profile →
  3. Biochemical Characterization of Human Collagenase-3
    1996 759 citations Vera Knäuper, Bryan Ronain Smith et al. Journal of Biological Chemistry profile →
  4. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors
    1999 712 citations Gillian Murphy et al. profile →
  5. Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation
    1996 647 citations Vera Knäuper, Horst Will et al. Journal of Biological Chemistry profile →
  6. A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases
    1992 637 citations Frances Willenbrock, Gillian Murphy et al. FEBS Letters profile →
  7. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
    1985 613 citations Andrew Docherty, Gillian Murphy et al. profile →
  8. Tumor Necrosis Factor-α-converting Enzyme (ADAM17) Mediates the Cleavage and Shedding of Fractalkine (CX3CL1)
    2001 538 citations Gillian Murphy et al. Journal of Biological Chemistry profile →
  9. The Matrix Metalloproteinases and Their Inhibitors
    1992 530 citations Gillian Murphy, Andrew Docherty profile →
  10. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
    2003 520 citations Gillian Murphy et al. profile →
  11. TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3
    1998 519 citations Augustin Amour, Vera Knäuper et al. FEBS Letters profile →
  12. The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A
    1998 510 citations Georgina S. Butler, Susan J. Atkinson et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Murphy United Kingdom 110 21.3k 14.2k 12.3k 7.5k 7.0k 314 38.0k
Hideaki Nagase United States 88 17.4k 0.8× 9.9k 0.7× 10.2k 0.8× 5.9k 0.8× 4.3k 0.6× 297 33.0k
William G. Stetler‐Stevenson United States 101 19.1k 0.9× 13.9k 1.0× 14.4k 1.2× 5.2k 0.7× 7.3k 1.1× 282 35.7k
Motoharu Seiki Japan 93 13.3k 0.6× 9.9k 0.7× 10.2k 0.8× 4.1k 0.5× 4.7k 0.7× 347 30.8k
Christopher M. Overall Canada 90 10.8k 0.5× 9.5k 0.7× 11.8k 1.0× 3.0k 0.4× 3.2k 0.5× 297 28.1k
Dylan R. Edwards United Kingdom 82 9.1k 0.4× 6.2k 0.4× 9.5k 0.8× 3.1k 0.4× 2.9k 0.4× 233 22.9k
Carl‐Henrik Heldin Sweden 132 8.9k 0.4× 14.1k 1.0× 41.7k 3.4× 3.8k 0.5× 5.1k 0.7× 494 62.7k
Keld Danø Denmark 87 16.6k 0.8× 7.5k 0.5× 7.8k 0.6× 9.0k 1.2× 5.5k 0.8× 218 23.8k
Ghislain Opdenakker Belgium 91 8.0k 0.4× 8.6k 0.6× 9.5k 0.8× 3.3k 0.4× 3.4k 0.5× 512 30.1k
David A. Cheresh United States 109 10.6k 0.5× 10.3k 0.7× 28.3k 2.3× 3.7k 0.5× 18.3k 2.6× 245 48.7k
Karl Tryggvason Sweden 96 6.8k 0.3× 4.8k 0.3× 15.1k 1.2× 3.6k 0.5× 9.8k 1.4× 384 34.3k

Countries citing papers authored by Gillian Murphy

Since Specialization
Citations

This map shows the geographic impact of Gillian Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Murphy more than expected).

Fields of papers citing papers by Gillian Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Murphy. The network helps show where Gillian Murphy may publish in the future.

Co-authorship network of co-authors of Gillian Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Murphy. A scholar is included among the top collaborators of Gillian Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Murphy. Gillian Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Gillian, David J. Brayden, David W. Cheung, et al.. (2025). Albumin-based delivery systems: Recent advances, challenges, and opportunities. Journal of Controlled Release. 380. 375–395. 19 indexed citations
2.
Carreca, Anna Paola, Veronica M. Pravatà, Gillian Murphy, et al.. (2020). TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1. Scientific Reports. 10(1). 25 indexed citations
3.
Tominari, Tsukasa, Chiho Matsumoto, Kenta Watanabe, et al.. (2017). Raloxifene reduces the risk of local alveolar bone destruction in a mouse model of periodontitis combined with systemic postmenopausal osteoporosis. Archives of Oral Biology. 85. 98–103. 7 indexed citations
4.
Bøtkjær, Kenneth A., Hang Fai Kwok, Mikkel G. Terp, et al.. (2016). Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo. Oncotarget. 7(13). 16773–16792. 34 indexed citations
5.
Nisato, Riccardo E., Christian Sirrenberg, Georgina S. Butler, et al.. (2005). Dissecting the Role of Matrix Metalloproteinases (MMP) and Integrin αvβ3 in Angiogenesis In vitro : Absence of Hemopexin C Domain Bioactivity, but Membrane-Type 1-MMP and αvβ3 Are Critical. Cancer Research. 65(20). 9377–9387. 54 indexed citations
6.
Nyalendo, Carine, Stéphanie Langlois, Yves Durocher, et al.. (2004). Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase. Journal of Biological Chemistry. 279(50). 52132–52140. 134 indexed citations
7.
Atkinson, Susan J., et al.. (2004). Cellular cholesterol regulates MT1 MMP dependent activation of MMP 2 via MEK‐1 in HT1080 fibrosarcoma cells. FEBS Letters. 566(1-3). 65–70. 17 indexed citations
8.
Sounni, Nor Eddine, Christian Roghi, Carine Munaut, et al.. (2004). Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine Kinases. Journal of Biological Chemistry. 279(14). 13564–13574. 114 indexed citations
9.
Lee, Meng‐Huee, Vandana Verma, K. Maskos, et al.. (2002). The C‐terminal domains of TACE weaken the inhibitory action of N‐TIMP‐3. FEBS Letters. 520(1-3). 102–106. 29 indexed citations
10.
Lafleur, Marc A., Peter Forsyth, Susan J. Atkinson, Gillian Murphy, & Dylan R. Edwards. (2001). Perivascular Cells Regulate Endothelial Membrane Type-1 Matrix Metalloproteinase Activity. Biochemical and Biophysical Research Communications. 282(2). 463–473. 40 indexed citations
11.
Saghizadeh, Mehrnoosh, Donald D. Brown, Raquel Castellon, et al.. (2001). Overexpression of Matrix Metalloproteinase-10 and Matrix Metalloproteinase-3 in Human Diabetic Corneas. American Journal Of Pathology. 158(2). 723–734. 96 indexed citations
12.
d’Ortho, Marie‐Pia, Horst Will, Susan J. Atkinson, et al.. (1997). Membrane‐Type Matrix Metalloproteinases 1 and 2 Exhibit Broad‐Spectrum Proteolytic Capacities Comparable to Many Matrix Metalloproteinases. European Journal of Biochemistry. 250(3). 751–757. 375 indexed citations
13.
Gohlke, U., F. Xavier Gomis‐Rüth, Thomas Crabbe, et al.. (1996). The C‐terminal (haemopexin‐like) domain structure of human gelatinase A (MMP2): structural implications for its function. FEBS Letters. 378(2). 126–130. 75 indexed citations
14.
Murphy, Gillian & Frances Willenbrock. (1995). [30] Tissue inhibitors of matrix metalloendopeptidases. Methods in enzymology on CD-ROM/Methods in enzymology. 248. 496–510. 220 indexed citations
15.
Williamson, Richard A., Gabriel Martorell, Mark D. Carr, et al.. (1994). Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry. 33(39). 11745–11759. 84 indexed citations
16.
Sorsa, Timo, Erkki Koivunen, Tuula Salo, et al.. (1994). HUMAN TUMOR-ASSOCIATED TRYPSIN(OGEN)-2 ACTIVATES 3 GENETICALLY DISTINCT BUT STRUCTURALLY HOMOLOGOUS HUMAN PRO-MATRIX METALLOPROTEINASES. Journal of Dental Research. 73. 201–201. 1 indexed citations
17.
Willenbrock, Frances & Gillian Murphy. (1994). Structure-Function Relationships in the Tissue Inhibitors of Metalloproteinases. American Journal of Respiratory and Critical Care Medicine. 150(6_Part_2). S165–S170. 83 indexed citations
18.
Mayer, Ulríke, Karlheinz Mann, Rupert Timpl, & Gillian Murphy. (1993). Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling. European Journal of Biochemistry. 217(3). 877–884. 63 indexed citations
19.
20.
Murphy, Gillian, et al.. (1977). The detection and characterization of collagenase inhibitors from rabbit tissues in culture. Biochimica et Biophysica Acta (BBA) - Enzymology. 483(2). 493–498. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideaki Nagase Breakdown of academic impact, for papers by William G. Stetler‐Stevenson Breakdown of academic impact, for papers by Motoharu Seiki Breakdown of academic impact, for papers by Christopher M. Overall Breakdown of academic impact, for papers by Dylan R. Edwards Breakdown of academic impact, for papers by Carl‐Henrik Heldin Breakdown of academic impact, for papers by Keld Danø Breakdown of academic impact, for papers by Ghislain Opdenakker Breakdown of academic impact, for papers by David A. Cheresh Breakdown of academic impact, for papers by Karl Tryggvason
Rankless by CCL
2026